AlphAIAlphAI — Financial news for AI agents
MarketBeatFEB 222 min read$OPCH

Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Rating of "Moderate Buy" by Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has received a consensus rating of "Moderate Buy" from twelve brokerages. Several firms, including Citigroup, Bank of America, Citizens Jmp, and Deutsche Bank, have issued "buy" or "outperform" ratings with target price increases. The company's stock is currently trading around $35.69, with solid financial metrics and substantial institutional ownership.

Original reporting
MarketBeat · MarketBeat
Published Feb 22, 2026, 6:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Feb 22, 2026, 6:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Rating of "Moderate Buy" by Brokerages — source image
Source · MarketBeat
Decision brief

The 30-second read

$OPCHBullishMed
01

Why it matters

The positive analyst ratings and target price increases suggest investor confidence, potentially leading to short-term price appreciation.

02

Market read

The news indicates a bullish outlook for OPCH, with potential positive ripple effects in related healthcare sectors.

03

What to watch

Potential macroeconomic headwinds or competitive pressures could impact stock performance despite positive analyst sentiment.

Timing: short to medium term (1-3 months)

Background

Option Care Health, Inc. specializes in providing home and alternate site infusion services, with recent earnings showing solid growth and expanding market share.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

High relevance due to positive analyst sentiment and institutional ownership.

Expected impact

Expected moderate price increase of approximately 5-8% over the next 1-3 months, contingent on continued positive analyst sentiment and earnings performance.

Evidence & confidence

Multiple reputable brokerages have issued buy ratings and increased target prices, indicating strong analyst confidence. Institutional ownership further supports upward momentum. Technical indicators (not provided) should be checked for confirmation.

Market effects

Sector

Positive sentiment may bolster the life sciences and healthcare services sectors.

Regional

Limited regional impact; primarily relevant to US markets.

Global

Moderate, as healthcare is a globally significant sector but this news is US-specific.

Counterpoint

What could challenge this read

Some analysts may view the 'Moderate Buy' rating as cautious; potential risks include sector regulation changes or earnings disappointments.

Key entities

  • Company
    Option Care Health, Inc.

    A provider of home infusion and pharmacy services.

  • Financial Institutions
    Brokerages

    Multiple firms including Citigroup, Bank of America, Citizens Jmp, and Deutsche Bank.

Read at source← All news

Related articles

JUL 31
$OPCHMed

Option Care Health, Inc. Q2 2026 Earnings Call Summary

Strategic Execution and Portfolio Recovery Performance beat driven by high-single-digit organic growth in the acute portfolio, where the company's national scale and local responsiveness facilitate time-sensitive hospital discharges. The chronic inflammatory disease (CID) portfolio reached a stabilization point following a first-quarter reset, with patient census beginning to rise sequentially despite biosimilar pricing headwinds.

yahoo.com6 min
JUL 29
$OPCHMedAI 8/10

Option Care Health (NASDAQ:OPCH) Posts Better

Option Care Health (OPCH) reported Q2 CY2026 revenue of $1.44 billion, up 1.9% year over year, beating Wall Street’s expectations. The company guided full-year revenue to about $5.73 billion. Non-GAAP profit was $0.45 per share, 5.4% above consensus. Shares rose about 6.5% to $23.95 after the release.

financialcontent.com5 min
JUL 29
$OPCHMed

Option Care Health, Inc. (OPCH): Results of Operations and Financial Condition

Option Care Health, Inc. (OPCH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026 BANNOCKBURN, IL., July 29, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternat

SEC EDGAR 8-K4 min
JUN 9
$OPCHMed

Option Care Health (OPCH) Stock Trades Up, Here Is Why

Option Care Health shares rose about 3.7% in the morning after Goldman Sachs initiated coverage with a Neutral rating and a $22 price target, implying upside from around $20.51. The stock had fallen 33% over six months. The article notes the company recently reported Q1 2026 revenue of $1.35B (+1.3% YoY) and cut full-year revenue guidance to a $5.73B midpoint.

markets.financialcontent.com4 min
SEP 18
$LMTHighAI 9/10

World News: Washington clears way for fighter jets sale to Saudi

The US approved a potential $24.3B sale of 48 Lockheed Martin F-35 fighter jets to Saudi Arabia, including engines and support equipment. The sale, a policy shift, may alter Middle East military balance and test US commitment to Israel's military edge. Saudi Arabia has long sought the advanced jets to modernize its air force and counter regional threats, particularly from Iran.

gdnonline.com2 min
SEP 18
$LMTHighAI 9/10

35 sale for Saudi Arabia

The US State Department approved a potential $24.3B sale of 48 F-35A fighters and 49 engines to Saudi Arabia, including support equipment and training. Lockheed Martin, the manufacturer, and RTX subsidiary Pratt & Whitney are involved. The deal requires congressional review and could face opposition due to security concerns. If finalized, it would make Saudi Arabia the 20th operator of the F-35.

breakingdefense.com2 min